Hepatitis Market Research Reports & Industry Analysis
Hepatitis Industry Research & Market Reports
-
Alcoholic Hepatitis – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Alcoholic Hepatitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Alcoholic Hepatitis market report provides current treatment practices, emerging drugs, Alcoholic ... Read More
-
Hepatitis B Vaccine Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... valued at USD 8.38 billion in 2023, and the market is now projected to grow from to USD 8.85 billion in 2024 to USD 13.31 billion by 2032, exhibiting a CAGR of 5.2% during the ... Read More
-
Liver Disease Therapeutic Market Report by Therapy Type (Anti-Rejection Drugs/Immunosuppressants, Chemotherapy Drugs, Targeted therapy, Vaccines, Immunoglobulins, Corticosteroids, and Anti-Viral Drugs) Disease Type (Non-alcoholic Fatty Liver Disease (NAFLD), Viral Hepatitis (B, C, D), Alcoholic Liver Disease (ALD), and Autoimmune Liver Disease (ALD)) End Users (Hospitals, Laboratories, and Others) Regions and Company Analysis 2024-2032
... (ALD), and Autoimmune Liver Disease (ALD)) End Users (Hospitals, Laboratories, and Others) Regions and Company Analysis 2024-2032 The market for Liver Disease Therapeutics is predicted to reach US$ 28.98 billion in 2032, increasing at a ... Read More
-
Hepatitis A – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Hepatitis A market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Hepatitis A market report provides current treatment practices, emerging drugs, Hepatitis ... Read More
-
Hepatitis C – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Hepatitis C market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Hepatitis C market report provides current treatment practices, emerging drugs, Hepatitis ... Read More
-
Hepatitis D – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Hepatitis D market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Hepatitis D market report provides current treatment practices, emerging drugs, Hepatitis ... Read More
-
North America Point-of-Care Molecular Testing for Infectious Diseases Market Size and Forecast (2021-2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage By: Diseases (HIV Testing, Influenza Testing, Sexually Transmitted Diseases Testing, Hepatitis C Virus Testing, Tropical Diseases Testing, Respiratory Infection Testing, Hospital Acquired Infections, Strep, Others), Technology (Lateral Flow Assay, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays, Solid Phase, Others), Prescription Testing (Prescription Based Testing, OTC Testing), Sample (Blood Sample, Urine Sample, Nasal and Oropharyngeal Swabs Sample, Others), End User (Hospitals and Clinics, Home Care Settings, Ambulatory and Urgent Care Facilities, Nursing Home and Assisted Living Facilities, Research Laboratories, Diagnostics Centers), Distribution Channel (E-Com Platforms, Retail Channel and Pharmacies, Others), and Country
... Testing, Tropical Diseases Testing, Respiratory Infection Testing, Hospital Acquired Infections, Strep, Others), Technology (Lateral Flow Assay, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays, Solid Phase, Others), Prescription Testing (Prescription Based Testing, OTC Testing), Sample (Blood Sample, Urine ... Read More
-
Antiviral Drugs Market, By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, and Others), By Type (Branded and Generics), By Application (HIV, Hepatitis, Herpes, Influenza, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) The global antiviral drugs market has been witnessing steady growth over the past few years. Antiviral ... Read More
-
Point-of-care Biosensors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Glucose Monitoring, HIV, Hepatitis C, Pregnancy), By Platforms (Microfluidics, Dipsticks, Immunoassays), By End User (Hospitals & Clinics, Pharmacy, Others) Region and Competition, 2019-2029F
... and Competition, 2019-2029F Global Point-of-care Biosensors Market was valued at USD 73.01 Billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 7.89% through 2029. The Global ... Read More
-
Global Hepatitis B Vaccines Market Research Report 2024
... of 6.45% during the forecast period 2024-2030. North American market for Hepatitis B Vaccines is estimated to increase from $ 568 million in 2023 to reach $ 964 million by 2030, at a CAGR of ... Read More
-
2024 Global Forecast for Hepatitis C Virus (Hcv) Testing Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD ... Read More
-
Global Hepatitis Diagnostic Test Databank Market Report
... 2023 to 2031. Blood tests segment is expected to be the highest contributor to this market, with $2,457.2 Million in 2022, and is anticipated to reach $3,721.6 Million by 2031, registering a CAGR of 4.76%. ... Read More
-
Global Hepatitis A Vaccine Market Analysis and Forecast 2024-2030
... age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally" 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric ... Read More
-
Global Hepatitis A Vaccine Market Size, Manufacturers, Opportunities and Forecast to 2030
... HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are ... Read More
-
Global Hepatitis A Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. ... Read More
-
Global Hepatitis A Vaccine Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
... of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines ... Read More
-
Hepatitis A Vaccine Industry Research Report 2024
... HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ... Read More
-
Sexually Transmitted Diseases Diagnostics Market Size, Trends, Analysis, and Outlook By Disease (CT/NG, Gonorrhea, HIV/AIDS, Genital Herpes, Hepatitis B, Syphilis, Mycoplasma Genitalium, Genital Warts, Candidal Vaginitis, Trichomoniasis, Bacterial Vaginosis, HPV, Others), By Test (Culture/Isolation Of Organisms, Molecular Test, Immunology Assay, Others), By Device (Laboratory Devices, Point Of Care (Poc) Devices), By End-User (Laboratory, Point of Care (POC)), by Country, Segment, and Companies, 2024-2032
... Organisms, Molecular Test, Immunology Assay, Others), By Device (Laboratory Devices, Point Of Care (Poc) Devices), By End-User (Laboratory, Point of Care (POC)), by Country, Segment, and Companies, 2024-2032 The global Sexually Transmitted Diseases Diagnostics market ... Read More
-
Hepatitis C Market Size, Trends, Analysis, and Outlook By Diagnosis (Liver Biopsy, Blood Tests), By Treatment (Antiviral Drugs, Immune Modulator Drugs, Others), By End-User (Hospitals and Clinics, Diagnostic Laboratory, Others), by Country, Segment, and Companies, 2024-2032
... 2024-2032 The global Hepatitis C market size is poised to register 12.8% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Hepatitis C ... Read More
-
Strand Displacement Amplification Market Size, Trends, Analysis, and Outlook By Application (Tuberculosis, Hepatitis, Malaria, Influenza, Cancer, Others), By End-User (Hospitals, Diagnostic laboratories, Others), by Country, Segment, and Companies, 2024-2032
... size is poised to register 5.6% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Strand Displacement Amplification market across By Application (Tuberculosis, ... Read More
-
Infectious Disease Drugs Market Size, Trends, Analysis, and Outlook By Disease (HIV, Influenza, Hepatitis, Tuberculosis, Malaria, Others), By Treatment (Antibacterial, Antiviral, Antiparasitic, Others), by Country, Segment, and Companies, 2024-2032
... size is poised to register 7.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Infectious Disease Drugs market across By Disease (HIV, ... Read More
-
Serological Testing Market Size, Trends, Analysis, and Outlook By Technology (ELISA, NAT, CLIA/CMIA, Others), By Product (Instruments, Consumables and Reagents), By Application (Hepatitis, Coronavirus, Human Immunodeficiency Virus, Rotavirus infections, Others), By End-User (Diagnostic Laboratories, Hospitals, Others), by Country, Segment, and Companies, 2024-2032
... Others), by Country, Segment, and Companies, 2024-2032 The global Serological Testing market size is poised to register 8.1% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry ... Read More
-
Diagnostic Specialty Antibodies Market Size, Trends, Analysis, and Outlook By Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Polyclonal Antibodies), By Application (Hepatitis, Tuberculosis, Dengue, Oncology, HIV, Infectious Disease, Others), By End-User (Hospitals, Diagnostic Laboratories, Others), by Country, Segment, and Companies, 2024-2032
... Country, Segment, and Companies, 2024-2032 The global Diagnostic Specialty Antibodies market size is poised to register 4.9% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
-
Me Too Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Beta Blockers, Antidepressants, Statins, Proton Pump Inhibitors, Benzodiazepines, Others), By Therapeutic Area (Oncology, Diabetes, Hepatitis C, Cardiovascular, Others), By Region and Competition, 2019-2029F
... By Region and Competition, 2019-2029F Global Me Too Drugs Market was valued at USD 364.81 Million in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.87% through ... Read More
-
Global Immunodiagnostics Market Size Study & Forecast, by Product (Instruments, Reagents & Consumables), By Application (Oncology & Endocrinology, Hepatitis & Retrovirus, Cardiac Markers, Infectious Diseases, Others), By End user (Clinical Laboratories, Hospitals, Physician’s Offices, Others), and Regional Analysis, 2023-2030
... and Regional Analysis, 2023-2030 Global Immunodiagnostics Market is valued approximately at USD 17.83 billion in 2022 and is anticipated to grow with a growth rate of more than 7.30% over the forecast period 2023-2030. Immunodiagnostics ... Read More
Research Assistance
